Bright Minds Biosciences Inc.
- DRUG
- NASDAQ
- Biotechnology
- CNS/Neuropsychiatric Drug Development
- Serotonin Agonists (5-HT2)
- Epilepsy Therapeutics
$51.30
Today −5.37%Quote Oct 16, 2026, 08:00 PM UTC
−16.65%over the last month
Max drawdown −21.6%From 1-month high −16.7%3 months −31.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$506.0M
Quote Oct 16
Next earnings
Dec 22
Expected, not confirmed
Analyst target
$171.67
+234.6% from here
Floor
$49.06
4.4% below price
Where the price sits
4 analysts
Analyst range, low to high
$145.00$220.00
- Price $51.30
- Resistance $52.35
- Consensus $171.67
The price is right under resistance. Analysts' average target sits about 235% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about DRUGPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
26
Founded
2017